Pulmagen Therapeutics
develops novel therapies to treat chronic respiratory diseases including asthma, severe asthma and COPD... Read morePulmagen Therapeutics
develops novel therapies to treat chronic respiratory diseases including asthma, severe asthma and COPD... Read more
Est. Annual Revenue
Est. Employees
News
Oct 10, 2018
BioPortfolio
Pulmagen Therapeutics: Pulmagen Therapeutics LLP Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 24072018 Prices from USD $250
Aug 24, 2018
BioPortfolio
Pulmagen Therapeutics: Pulmagen Therapeutics LLP Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 09052018 Prices from USD $250
Mar 24, 2018
BioPortfolio
Pulmagen Therapeutics: Pulmagen Therapeutics LLP Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14032018 Prices from USD $250
Dec 01, 2017
BioPortfolio
Pulmagen Therapeutics: Pulmagen Therapeutics LLP Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 09112017 Prices from USD $250
Oct 14, 2017
BioPortfolio
Pulmagen Therapeutics: Pulmagen Therapeutics LLP Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14092017 Prices from USD $250
Mar 25, 2017
BioPortfolio
Pulmagen Therapeutics: Pulmagen Therapeutics LLP Pharmaceuticals Healthcare Deals and Alliances Profile Updated 21022017 Prices from USD $250
Dec 14, 2016
FierceBiotechIT
Pulmagen Therapeutics: Pulmagen med passes phase 2 asthma test, seeks partner for late-stage trials
Dec 13, 2016
BioSpace
Pulmagen Therapeutics: Positive Phase II In Eosinophilic Asthma For Teijin Pharma
Nov 17, 2016
BioPortfolio
Pulmagen Therapeutics: Pulmagen Therapeutics LLP Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250
May 13, 2015
PR-INSIDE.COM
Press Release: Pulmagen Therapeutics : Newly released market study: Pulmagen Therapeutics LLP - Pharmaceuticals & Healthcare - Deals and Alliances Profile
